Crossmark

SALL4 promotes angiogenesis in gastric cancer by regulating VEGF expression and targeting SALL4/VEGF pathway inhibits cancer progression

Crossref DOI link: https://doi.org/10.1186/s12935-023-02985-9

Published Online: 2023-07-31

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Abouelnazar, Fatma A.

Zhang, Xiaoxin

Zhang, Jiahui

Wang, Maoye

Yu, Dan

Zang, Xueyan

Zhang, Jiayin

Li, Yixin

Xu, Jing

Yang, Qiurong

Zhou, Yue

Tang, Haozhou

Wang, Yanzheng

Gu, Jianmei

Zhang, Xu
Funding

Funding for this research was provided by:

Key Laboratory of Molecular Diagnostics and Precision Medicine for Surgical On-cology in Gansu Province ((2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02), (2019GSZDSYS01, 2019GSZDSYS02))

Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences ((NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002), (NLDTG2020002))

Priority Academic Program Development of Jiangsu Higher Education Institutions ((PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD), (PAPD))

Nantong Science and Technology Bureau Project ((JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092), (JC2021092))

Postgraduate Research & Practice Innovation Program of Jiangsu Province ((KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713), (KYCX21_3405, KYCX22_3713))
License Information

Text and Data Mining valid from 2023-07-31

Version of Record valid from 2023-07-31
More Information

Article History

Received: 16 January 2023

Accepted: 4 July 2023

First Online: 31 July 2023

Declarations

:

: All experiments were permitted by Jiangsu Key Laboratory of Medical Science and Laboratory Medicine, School of Medicine, Jiangsu University.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below